
Investments pave way for type 2 diabetes breakthrough
French biotech AdipoPharma is developing a novel and promising type 2 diabetes drug, for which it has successfully secured the funding needed to begin Phase I clinical trials. The company expects to begin clinical trials in the US in mid-2025. This funding will enable AdipoPharma to accelerate… Read More














